Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort study.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
05 2023
Historique:
received: 08 02 2023
accepted: 08 04 2023
medline: 23 5 2023
pubmed: 22 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

The risk of infection after exposure to clade IIb mpox virus (MPXV) is unknown, and potential presymptomatic shedding of MPXV remains to be demonstrated. High-risk contacts of mpox patients were followed-up in a prospective longitudinal cohort study. Individuals reporting sexual contact, >15 min skin-to-skin contact, or living in the same household with an mpox patient were recruited in a sexual health clinic in Antwerp, Belgium. Participants kept a symptom diary, performed daily self-sampling (anorectal, genital, and saliva), and presented for weekly clinic visits for physical examination and sampling (blood and oropharyngeal). Samples were tested for MPXV by PCR. Between June 24 and July 31, 2022, 25 contacts were included, of which 12/18 (66.0%) sexual and 1/7 (14.0%) nonsexual contacts showed evidence of infection by MPXV-PCR. Six cases had typical mpox symptoms. Viral DNA was detected as early as 4 days before symptom onset in 5 of them. In 3 of these cases, replication-competent virus was demonstrated in the presymptomatic phase. These findings confirm the existence of presymptomatic shedding of replication-competent MPXV and emphasize the high risk of transmission during sexual contact. Sexual contacts of mpox cases should abstain from sex during the incubation period, irrespective of symptoms.

Identifiants

pubmed: 37212312
doi: 10.1002/jmv.28769
doi:

Banques de données

ClinicalTrials.gov
['NCT05443867']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28769

Informations de copyright

© 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Geneva: World Health Organization. 2022 Mpox (Monkeypox) outbreak: global trends [Internet]. https://worldhealthorg.shinyapps.io/mpx_global/
Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med. 2022;387:1783-1793.
Palich R, Burrel S, Monsel G, et al. Viral loads in clinical samples of men with monkeypox virus infection: a French case series. Lancet Infect Dis. 2023;23(1):74-80. https://pubmed.ncbi.nlm.nih.gov/36183707/
Colavita F, Antinori A, Nicastri E, et al. Monkeypox virus in human body sites and fluids: evidence for transmission. Lancet Infect Dis. 2023;23(1):6-8.
Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries-April to June 2022. N Engl J Med. 2022;387(8):679-691. https://www.nejm.org/doi/10.1056/NEJMoa2207323
World Health Organization. Clinical management and infection prevention and control for monkeypox. Interim rapid response guidance. 2022;(June):76.
European Centre for Disease Prevention and Control (ECDC). Considerations for contact tracing during the monkeypox outbreak in Europe, 2022.
De Baetselier I, Van Dijck C, Kenyon C, et al. Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium. Nat Med. 2022;16.
Van Dijck C, Hens N, Kenyon C, Tsoumanis A. The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium: a modeling study. Clin Infect Dis. 2023;76(3):e1421-e1423.
Ferré VM, Bachelard A, Zaidi M, et al. Detection of monkeypox virus in anorectal swabs from asymptomatic men who have sex with men in a sexually transmitted infection screening program in Paris, France. Ann Intern Med. 2022;175(10):1491-1492. https://pubmed.ncbi.nlm.nih.gov/35969863/
Accordini S, Cordioli M, Pomari E, Tacconelli E, Castilletti C.People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission. Lancet Microbe. 2023;4(4):e209. https://pubmed.ncbi.nlm.nih.gov/36563704/
Ward T, Christie R, Paton RS, Cumming F, Overton CE. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study. BMJ. 2022;379(May):e073153.
Nishiura H, Linton NM, Akhmetzhanov AR. Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis. 2020;93(January):284-286.
Freeman EE, Abbott S, Kurpiel B, Okwor T. The dynamics of monkeypox transmission. BMJ. 2022;379:o2504. https://www.bmj.com/content/379/bmj.o2504
Ogale Y, Yeh PT, Kennedy CE, Toskin I, Narasimhan M. Self-collection of samples as an additional approach to deliver testing services for sexually transmitted infections: a systematic review and meta-analysis. BMJ Glob Health. 2019;4(2):e001349. https://gh.bmj.com/content/4/2/e001349
Ubals M, Tarín-Vicente EJ, Oller X, et al. Evaluating the accuracy of self-collected swabs for the diagnosis of monkeypox. Clin Infect Dis. 2023;76(7):1311-1314. https://pubmed.ncbi.nlm.nih.gov/36370091/
World Health Organization. Self-collection of samples for sexually transmitted infections (‎‎STIs)‎‎ [Internet]. https://www.who.int/publications/i/item/WHO-SRH-20.10
Li Y, Zhao H, Wilkins K, Hughes C, Damon IK. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virol Methods. 2010;169(1):223-227.
de Baetselier I, van Dijck C, Kenyon C, et al. Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium. Nat Med. 2022;28(11):2288-2292. https://pubmed.ncbi.nlm.nih.gov/35961373/
Minhaj FS, Petras JK, Brown JA, et al. Orthopoxvirus testing challenges for persons in populations at low risk or without known epidemiologic link to monkeypox-United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(36):1155-1158.

Auteurs

Isabel Brosius (I)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Christophe Van Dijck (C)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.

Jasmine Coppens (J)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Leen Vandenhove (L)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Eugene Bangwen (E)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Fien Vanroye (F)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Jacob Verschueren (J)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Sabine Zange (S)

Bundeswehr Institute of Microbiology, Munich, Germany.

Joachim Bugert (J)

Bundeswehr Institute of Microbiology, Munich, Germany.

Johan Michiels (J)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Emmanuel Bottieau (E)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Patrick Soentjens (P)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Johan van Griensven (J)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Chris Kenyon (C)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa.

Kevin K Ariën (KK)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Marjan Van Esbroeck (M)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Koen Vercauteren (K)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Laurens Liesenborghs (L)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH